FDA Inspection 1163479 — ObsEva, S.A.

ObsEva, S.A. — FEI 3020706317

The FDA completed an inspection of ObsEva, S.A. on Mar 2, 2022 in Plan-Les-Ouates. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Mar 2, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Plan-Les-Ouates (Switzerland)

Additional Details

Sponsor, Contract Research Organization

Citations

IDCFRDescription
748221 CFR 312.50General responsibilities of sponsors